Novartis AG
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

Abstract:

The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; ##STR00001## a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.